N. Wickremasinghe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
N. Wickremasinghe has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Anuradha Supun Dassanayake
Colombo North Centre for Liver Disease, Faculty of Medicine University of Kelaniya Ragama Sri Lanka
2 shared publications - Anushka Mudalige
Medical Intensive Care Unit, Colombo North Teaching Hospital
2 shared publications - Bhagya Gunetilleke
Colombo North Centre for Liver Diseases Faculty of Medicine University of Kelaniya Sri Lanka
2 shared publications C. Liyanage
University of Kelaniya
2 shared publications- Danushi Jayaweera
University of Kelaniya
2 shared publications - Dineshani Hettiaracchchi
Department of Anatomy, Genetics and Biomedical Informatics, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka
2 shared publications
Latest Publications
- Open Access
- 30 November 2021
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Surgery
- Vol. 39 (3) , 36-42
Fifty liver transplants: a single centre experience of haemodynamic management in liver transplantation for cirrhosis [part 2]
Globally, an estimated one million deaths occur annually due to complications of cirrhosis. Cirrhosis with end stage liver disease [ESLD] is a leading cause death due to noncommunicable diseases in Sri Lanka. Non-alcoholic fatty liver disease [NAFLD] and alcohol related liver disease [ARLD] are the principal causes of ESLD due to cirrhosis in Sri Lanka. Liver transplantation remains the only curative treatment for such patients. Multiorgan dysfunction and hemodynamic instability characteristic of ESLD adds to the complexity of perioperative care in liver transplantation. Maintenance of stable hemodynamics including optimal hemostasis forms the core of the anaesthetic strategy in liver transplantation.
- 30 November 2021
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Surgery
- Vol. 39 (3) , 36-42
Open AccessFifty liver transplants: a single centre experience of haemodynamic management in liver transplantation for cirrhosis [part 2]
Globally, an estimated one million deaths occur annually due to complications of cirrhosis. Cirrhosis with end stage liver disease [ESLD] is a leading cause death due to noncommunicable diseases in Sri Lanka. Non-alcoholic fatty liver disease [NAFLD] and alcohol related liver disease [ARLD] are the principal causes of ESLD due to cirrhosis in Sri Lanka. Liver transplantation remains the only curative treatment for such patients. Multiorgan dysfunction and hemodynamic instability characteristic of ESLD adds to the complexity of perioperative care in liver transplantation. Maintenance of stable hemodynamics including optimal hemostasis forms the core of the anaesthetic strategy in liver transplantation.
- Open Access
- 31 July 2021
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Surgery
- Vol. 39 (2) , 63-67
Fifty liver transplants: a single centre experience of haemodynamic management in liver transplantation for cirrhosis [part 1]
Cirrhosis with end stage liver disease (ESLD) is a leading cause of non-communicable disease related deaths in Sri Lanka. Liver transplantation is the only curative treatment for patients with ESLD. The complex multisystem involvement and unique cardiovascular profile characteristic of ESLD present formidable challenges during liver transplantation. Management of the rapid and varied hemodynamic changes during surgery requires an in depth understanding of the physiological effects of each intervention. Based on the current literature and the experience gained at our center during the management of 50 liver transplants, we present optimization strategies and perioperative hemodynamic interventions which we use to ‘Fast track’ recovery following liver transplantation.
- 31 July 2021
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Surgery
- Vol. 39 (2) , 63-67
Open AccessFifty liver transplants: a single centre experience of haemodynamic management in liver transplantation for cirrhosis [part 1]
Cirrhosis with end stage liver disease (ESLD) is a leading cause of non-communicable disease related deaths in Sri Lanka. Liver transplantation is the only curative treatment for patients with ESLD. The complex multisystem involvement and unique cardiovascular profile characteristic of ESLD present formidable challenges during liver transplantation. Management of the rapid and varied hemodynamic changes during surgery requires an in depth understanding of the physiological effects of each intervention. Based on the current literature and the experience gained at our center during the management of 50 liver transplants, we present optimization strategies and perioperative hemodynamic interventions which we use to ‘Fast track’ recovery following liver transplantation.